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Diagnostic cardiac catheterization is performed in > 1 million 
patients a year in the United S,tates (I ,2), of whom approx- 
imately 50% may be suitable for an outpatient procedure (3). 
Reports (4-7) of outpatient catheterization have provided 
data on cost factors and risk groups that are suitable for this 
approach. Outpatient cardiac catheterization has also been 
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favored for suitable patients by several prepaid hosnital 
plans, as well as major insurance companies and third party 
payers. Increasing numbers of patients undergoing cardiac 
catheterization can be anticipated, and they will include 
patients with heart transplantation needing angiographic and 
hemodynamic follow-up study, those admitted to intensive 
care units with a chest pain syndrome and those with cardiac 
arrhythmias or coronary angioplasty with multiple revisits 
for chest pain. Early discharge from an outpatient facility 
might reduce the cost and increase the utilization of the 
facilities. 
However, same day (or earlier [6 to 8 h]) patient dis- 
charge may result in bleeding at the puncture site with 
commonly used 7 and 8 French (F) femoral angiographic 
catheters (8,9). Although most laboratories (10-12) report a 
low incidence of vascular complications after femoral cath- 
eieriz&il &li W or 3F catheters after 18 h of patient 
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immobilization, the potential for significant arterial bleeding 
remains a practical concern for most cardiologists. For that 
reason, earlier ambulation and discharge are not generally 
attempted. 
Bleeding complications are reduced with SF catheters, 
but the use of smaller diagnostic catheters has not been 
widely accepted because of unsatisfactory angiographic re- 
suits (13). With the use of an innovative, large lumen 5F 
catheter (Sherwood Medical Company) previous problems 
related to suboptimal coronary angiography (poor coronary 
opacification, poor catheter handling and seating) have been 
overcome. Because early ambulation and early patient dis- 
charge may have a significant impact on the practice of 
outpatient cardiac catheterization, we performed a prospec- 
tive multicenter clinical pilot trial to assess the safety, 
complications and cardiac events related to early ambulation 
after 5F left heart catheterization. 
Study patients. From August 1988 until March 1989,287 
patients underwent diagnostic left heart catheterization and 
selective coronary arteriograpby in five medical centers by 
experienced cardiologists with and without fellows in train- 
ing (see Appendix 2). Patients underwent investigation for a 
chest pain syndrome, assessment of the extent and severity 
of suspected or known coronary artery disease, valvular or 
myopathic heart disease or cardiac transplantation follow-up 
examination (Appendix 1). The protocol for early ambula- 
tion was approved by appropriate institutional review com- 
mittees at each institution. No patients were excluded on the 
basis of gender, age, weight, body condition or clinical 
presentation. Outpatient catheterization was defined as a 
procedure performed on the morning of patient admission 
with discharge on the same day, usually ~12 h but always 
~23 h after admission. 
Two hundred sixty patients (91%-j participated in the early 
ambulation protucol. Twenty-seven patients were excluded; 
reasons for exclusion included the requirement for continued 
heparin and arterial sheath placement before either angio- 
ylasty or coronary artery bypass surgery (n = 24) and use of 
7F or 8F catheters (n = 3) because of unusually difficult 5F 
catheter placement or suboptimal angiograms, or both. A 6F 
sheath was used in 19 patients. Seven procedtucs used the 
side arm lumen pressure for hemodynamic ritudies, and in 12 
patients, normal anatomic variations required catheter con- 
figurations unavailable in the initial 5F catheter series. These 
patients were included in the early ambulation protocol. 
Techniques for diagnostic left heart catheterization. This 
procedure was performed according to the established rou- 
tine at each clinical center using standard Seldinger and 
Judkins femoral artery techniques in all patients. A 5.2F 
arterial sheath (either USC1 or Cordis) was placed in the 
femoral artery. Only four SF catheter configurations were 
available at the time of study: left 4 cm Judkins curve, right 
modified Amplatz, Noto right coronary curve and Sher 
open pigtail ventriculography catheter. The order of 
nary arteriography and left ventriculography was determined 
by the attending physician. Room temperature ionic or 
nonionic contrast medium was used for routine angiography 
at each laboratory. Coronary angiography was performed by 
hand injection. Multiple-angled standard views of the left 
and right coronary arteries and left ventriculography were 
performed as indicated by the clinical condition. Routine 
premeditations were given per laboratory protocols 
included diazepam, diphenhydramine, sublingual nitrog 
erin and atropine. Cardiac medications were continued as 
clinicallv indicated. The use of heparin was in keeping with 
the rourine laboratory procedures at the particular study 
center and was not varied for use of the large lumen 5F 
catheters for the purposes of this evaluation. The 
dose of intravenous heparin ranged from 1,500 to 
and the need for reversal by protamine sulfate (25 to 50 mg) 
was determined by the operator at the time of study. 
Early ambulation protocol. After completion of the diag- 
nostic study, the puncture site was compressed either man- 
ually or with a mechanical compression clamp for an average 
time of 15 min (range 5 to 50). Blood pressure and immediate 
postcompression puncture site status were recorded by a 
nurse in the holding area. The target ambulation time was 1.5 
h. However, because of lo@stic difficulties, the physician 
occasionally could not return to the patient at precisely the 
target hour. Patients remained at bed rest for an average of 
2.6 h (range 1.8 to 3.1). after Tarhich with a physician at the 
bedside, the patient was asked to stand and walk. After early 
ambulation, the patient’s activities were unlimited. Qutpa- 
tients were discharged the same evening, inpatients the next 
morning. A follow-up phone call regarding the presence of 
hematoma, puncture site pain and other complications was 
made to outpatients 24 to 72 h after discharge. A sample of 
the questions asked at the follow-up call is provided in 
Appendix I. 
Angiograpbic technique, The radiographic contrast me- 
dium used was either ionic or nonionic, in keeping with the 
laboratory’s standard practices. Coronary injections were 
performed by hand using 6 to 10 ml of contrast medium. Film 
framing rates varied from 301s to 60/s. The rate of contrast 
injection for ventriculography ranged from I2 to 16 cc/s for 
total volumes of 36 to 48 cc. A qualitative assessment of 
coronary angiography, ventriculography, difhculty of cathe- 
ter positioning and need to change catheters was made for 
each patient. Angiographic studies were rated by the oper- 
ating physicians as acceptable or unacceptabt,e in compari- 
son with prior studies in their laboratories using their Stan- 
dard larger (7F or 8F) diameter catheters. 
TO assess whether angiographic data were comparable 
with those obtained with ?F or BF catheters, a two part pilot 
angiographic study for an additional 63 patients (not part of 
ca~~MlaIiQm~ com- 
/recoil catheter r 
hit score was 3.4 L 
ic score was 3.9 + 0.6 (range 3.7 2 0.7 
two films bad a score <3 by both 
reviewers. 
~aa~t~tat~ve analysis of coronae; aag~agra~~ic q~lai~ty 
iversit31. Image data were ac- 
computer system by digitizing 
of a coronary lesion (84). 
Quantitative analysis of normal vessel d 
stenosis was obtained with use cf a s 
detection algorithm (ART ) and by using the catheter 
lumen as a scaling factor 414). Thirty coronary a~g~ograms 
(not part of this report) were analyzed (l0 obtained with SF, 
10 with 6F and 110 with 7F coronary catheters). In 20 
additional patients, coronary angiograms were compared 
directly using both 8F and 5F catheters in the same patient in 
identical (randomized 5F or 8F, left 
views with analysis of angiograms pe 
dent reviewers (catheters could not 
Interobserver correlations for normal arterial diameter and 
percent lesion stenosis revealed an r value of O.&O (SEE = 
0.64 mm) and 0.38 (SEE = 4.02%), respectively, for 5F; 0.81 
(SEE =z 0.65 mm) and 0.85 (SEE = 5.5%) for 6F and 0.94 
(SEE = 0.56 mm) and O.g4 (SEE = 6.9%) for 7F independent 
group catheter data. Intraobserver variability for normal 
diameter and percent stenosis rev:caled an I’ value of 0.85 
(SEE = 0.48 mm) and 0.94 (SEE = 8%) fix 5F and 0.88 
(SEE = 0.73 mm) and 0.82 (SEE I- .5%) for 71: catheter 
data, respectively. In the 5F and gF catheter comparisons, 
the inter- and intraobserver variability using the catheter 
cahbration factors was exceltent, with a linear relation for 
both the SF (r = 0.83) and 8F (r = 0.97) catheters. Measure- 
ments of normal vessel size using catheter calibrations 
demonstrated satisfactory linearity (5F, r = 0.63, SEE = 
ar coronary were obtained for the 
ythmia ~e~~iri~g Card~overs~oR, vas- 
transfusion, surgical consultation or 
mor complications included hematoma or vas- 
ovagal event. After cat e~~zat~o~, early bematoma was 
the time of compression to early 
ccurred from early ambulation 
deviation of variables studied. uare analysis and rela- 
factors were more prevalent in patients who developed a 
minor hematoma after early amb~latio~. Statistical signifi- 
cance was accepted with 
sented as mean values + i SD. 
weight (78 t 17 kg) and height (170 
Patient age, gender, 
+ I.3 cm) distribution 
among the study centers was similar. Heparin was given to 
127 patients (44% of total) and ranged from 17% to 75% of 
patients at each center. One hundred thirty-six patients 
(47%) were taking aspirin before catheterization and 22 
patients (8%) were also receiving di~yri~amole, One hun- 
dred seventy-five patients (61%). comprising 16% to 91% of 
patients at each study center, had studies performed as an 
inpatient. 
CIlinical indicatians ( able I). The majority of patients 
(n = 231 [SO%]) had left heart catheterization performed on 
an elective basis. One patient had an emergency catheter- 
ization, and 38 (13%) had urgent indications for catheteriza- 
tion at the earliest available time. 
Clinical conditions for patients unde “going diagnostic 
catheterization iachded unstable angina (: 2 patients ]29%]), 
stable angina (63 patients [22%]), myoca *dial dysfunctian/ 
(cardiomyopathy (33 patients [I I%]), atypical angina] chest 
pain (30 patients [lo%]), follow-up coronary angioplasty 426 
patients [90/o]), congestive heart fa ure (7 patients W51) and 
angina after coronary artery by ss surgery (6 patients 
[3%1). 
Normal coronary a~eriographic findings were present in 
95 patients (33%), with a range of 23% to 44% of patients at 
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Table 1. Results of 5F Left Heart Ctttheterization 
Total 
Variables No. % 
No. of patients 
No. with early ambulation 
Age (yr) (mean, range) 
No. of men 
Indications 
1. Emergency 
2. Urgent 
3. Elective 
4,Other/miscellaneous 
Conditions 
I. Unstable angina 
2. Cardiogenic shock 
3. Stable angina 
4. Atypical chest pain 
5. Acute or recent myocardial infarction 
6. Myocardial disease 
7. Follow-up FTCA 
8. Follow-up CABG 
9. Congestive heart failure 
IO. Other/miscellaneous 
Medications 
Heparin 
Aspirin 
Dipyridamole 
CAD 
Normal study 
I vessel 
2 vessel 
23 vessel 
Procedure variables 
Systolic pressure (mm Hg) 
Diastolic pressure (mm Hg) 
LVEF (%) 
Hours immobile 
Ambulated at (h) 
Fluoroscopic time (mm) 
Arterial time (min) 
Compression time (min) 
Clamp compression (no.) 
Early hematoma (~4 h) 
Late hematoma (<24-48 h) 
Inpatients 
Major complications 
287 
268 (91) 
58 (25-91) 
166 (58) 
I (0.3) 
38 (13) 
231 (80) 
I7 (6) 
82 (19) 
0 (0) 
63 (22) 
30 (IO) 
I2 (4) 
I6 (6) 
26 (9) 
6 (2) 
7 (2) 
33 (Ii) 
127 (144 
136 (47) 
22 (8) 
95 (33) 
70 (24) 
64 (22) 
58 (20) 
130 f 23 
76r II 
54 t I5 
2.81 f I.6 
2.61 ?z I.1 
6.63 + 4.7 
25.70 f 13.1 
15.1 + 12.6 
65 
14 
9 
I75 
3 
- 
- 
- 
- 
- 
- 
- 
(23) 
(6)* 
(4)* 
(61) 
(I) 
*See TaMe 2. CABG = coronary artery bypass graft surgery; CAD = 
coronary artery disease; LVEF = left ventricular ejection fraction; FTCA = 
percutaneous coronary angiography. 
the centers, Single, double and triple vessel coronary artery 
disease was present in 70 (24%), 64 (22%) and 57 patients 
(20%), respectively. Mean left ventricular ejection fraction 
was 54 k U%, ranging from 53 + 11% to 58 -c 17% among 
the clinical centers, - 
My ambulation (Table 1). 
(91%) participated in the early 
Of the 287 patients, 260 
ambulation protocol. The 
average blood pressure at the time of catheter removal was 
130 + 23/76 + 11 mm Hg. Patients were ambulated an 
average of 2.6 + 1.1 h (range 1.8 to 3.1) after puncture site 
compression for a mean time of 15.1 + 12.8 min (range 5.4 to 
52). A mechanical puncture site compression clamp was 
used in 65 (23%) patients. 
Maor complications. Three patients had a major compli- 
cation as a result of cardiac catheterization. There were no 
deaths or myocardial infarctions. One patient, a 78 year old 
man, had a transient ischemic attack with only transient 
aphasia during SF right Noto coronary catheter placement. 
His left ventricular ejection fraction was 63%; Aphasia was 
in resolution at follow-up evaluation. Arterial time was 18 
min; heparin, but no aspirin, was used. Because of the 
limited and near complete resolution of symptoms, ambula- 
tion at 4 h was uncomplicated. 
Two patients had ventricular tachycardia requiring direct 
carrent cardioversion during left ventriculography. The first 
patient was a 64 year old woman with triple vessel coronary 
artery disease and a left ventricular ejection fraction of 45%. 
There were no complications after cardioversion, and she 
participated in the early ambulation protocol without com- 
plications. The second patient was a 67 year old man with a 
left ventricular ejection fraction of 30%. The study required 
a 6F multipurpose catheter because of anatomic variation. 
Ventricular tachycardia during ventriculography with tbe 6F 
multipurpose catheter occurred with successful direct cur- 
rent cardioversion. The patient had single vessel coronary 
artery disease. His blood pressure was 148/72 mm Hg at the 
end of the procedure, and he was ambulated at 4 h after 
cardiac catheterization without hematoma. 
Minor complications (hematoma) (Table 2). Twenty pa- 
tients had a minor hematoma after early ambulation. Four- 
teen patients had a hematoma early after cardiac catheter- 
ization, nine patients had a late hematoma and two patients 
had both early and late hematomas. Of the patients who had 
a hematoma, nine received heparin, eight received aspirin 
and six received both. Four patients had a 6F sheath used to 
accommodate the different angiographic catheters needed. 
When patients with and without hematoma were com- 
pared, no correlations were found for severity of coronary 
atherosclerosis (triple vessel coronary artery disease, n = 5), 
depressed left ventricular ejection fraction (<45%, n = 7). 
elevated systolic pressure (~130 mm Hg, n = 10) after 
cardiac catheterization, age >70 years, use of heparin (odds 
ratio 1.79, range 0.77 to 4.16) or aspirin (odds ratio 1.21, 
range 0.52 to 2.80), arterial compression time 215 min (odds 
ratio 0.79, range 0.33 to 1.94) or tota! arterial time 230 min 
(odds ratio 3.0, range 1.29 to 7.10). Chi-square analysis 
indicated that hematoma occurred in a higher percent of 
patients receiving both heparin and aspirin (p < U.01; odds 
ratio 3.07, range 1.28 to 7.53) and compression time cl0 min 
(p = 0.008; odds ratio 3.0, range 1.29 to 7.10). 
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Table 3. Reported Results of Early Ambulation After Cardiac Catheterization 
Readmission 
of 
Catheter* Total 
Size Heparin (%I Ambulation Outpatients 
Outpatients 
Arterial Hematoma 
Author (reD Year No. (French) Asp (%) Time (h) (%) No. (%I CVA VT Injury Rate (%) 
Block et al. (7) 1988 381 7.8 (100%) “Inpatient” >5 20 14 (7.31 0 0 0 12 
N/A 
Pink et al. (9) 1989 loo0 8 (100%) “All” >6 20 45 (4.5) 4 (0.4) 4 (0.4) 2 (0.2) N/A 
N/A 
Oldroyd et al. (23) 1989 900 7.8 (100%) N/A .4 100 6 (0.6) I (0.1) 4 (0.4) 8 (0.8) 12 
N/A 
Klinke et al. (I41 1985 3071 8+ (98%) N/A >4 83 34 (I.11 4 (0.14) 13 (0.4) II (0.35) N/A 
N/A 
Current study 1990 287 5 (92%) 44 >I.8 39 0 (0) I (0.4) 2 (0.7) 0 (0) 8 
47 
*Number in parentheses is percent of patients completed with this catheter size; tsize not stated, but assumed. Asp = aspirin: CVA = cerebrovascular 
accident: N/A = information not available: VT = ventricular tachycardia. 
Procedure variables. Ninety-two percent of patients 
(n = 263) had only the lye lumen 5F catheter configurations 
used during their study. Because of normal anatomic varia- 
tions, 50 patients (17%) required a change to a different 
shape catheter unavailable in 5F size at the time of this study 
(Amplatz, multipurpose; left 3.5, 5 cm Judkins). The dif- 
ferent catheter configurations used included 6F left 3.5 cm 
Judkins (n = 7), left 4 cm Judkins (n = l), left 5 cm Judkins 
(n = A), left 6 cm Judkins (n = I), 6F right 4 cm Judkins 
(n = 4), 6F multipurpose (n = 4). 5F modified Amplatz to 
change from right “Noto” design (n = 22), multipurpose 
(n = 3) and 5F right 4 cm Judkins (n = 4). Only three patients 
had angiography with a 7F or 8F catheter. 
The averagejluroscopic time was 6.6 2 4.7 min (range 4.8 
io 8.2). The average arterial time from puncture to sheath 
removal was 25.7 2 13.1 (range 16.6 to 30.3). 
Late clinical events. No patient had a cardiac event, 
unstable angina after discharge or other reasons for readmis- 
sion within 24 to 72 h after large lumen 5F cardiac catheter- 
ization with early ambulation. 
iscussion 
The results of this prospective pilot trial indicate that 
early ambulation (~3 h) after large lumen SF diagnostic 
femoral cardiac catheterization can be accomplished safely 
within minimal complications and without compromise of 
ty. 
or 8F diagnostic catheters (Table 3). 
The majority of studies (14-20) reporting complication rates 
and standards of care have been performed using 7F or 8F 
diagnostic equipment. In no study was early ambulation 
attempted. Brown and MacDonald (13) compared complica- 
tions using both 5F and 7F catheters and reported only two 
minor groin hematomas after 7 h of bed rest occurring in 100 
patients studied with a 5F catheter; this rate was not sig- 
nificantly different from the (low but unspecified) complica- 
tion rate obtained with 7F catheters in the same institution. 
However, the postcatheterization recovery time using 5F 
catheters was reduced only by 1 h from the routine of 8 h of 
bedrest after diagnostic studies. The investigators indicated 
that the time to ambulation could probably be reduced fur- 
ther, but early ambulation (that is, <7 h) was not evaluated. 
In a preliminary study, Klinke et al. (8) compared the 
time to hemostasis using SF and 7F or 8F catheters. Fifty- 
two patients with similar age, body weight and blood pres- 
sure were randomized to 5F or 7F left heart catheterization. 
Fifteen of 26 patients in the 5F group (compared with 0 of 26 
in the 81: group) demonstrated poor catheter torque control 
and 4 (compared with 0 patients) I;,J unsatisfactory angio- 
grams. The time to hemostasis, however, was reduced 
significantly to 19 f 6 from 28 +- 11 min. Puncture site 
hematomas occurred in 18% and 1% of both 5F and 8F 
groups, respectively. Late postcatheterization bleeding did 
not occur in any patient in the 5F group, but occurred in 3 
(12%) of 26 patients in the 8F group. There was no difference 
in procedure (25 C I1 min) or fluoroscopic (4.4 + 2.6 min) 
times. In this unique comparison study, although the 5F 
catheters reduced the time to hemostasis, the advantage was 
offset by the frequent need to change to larger catheters, 
poor torque control or poor quality of cineangiograms. With 
the use of the newer large lumen 5F catheters in our study, 
these disadvantages were eliminated and, as demonstrated, 
the advantage in hemostasis realized. 
Complications associated with outpatient cardiac catheter= 
ization. Complications of outpatient catheterization have 
been reported by Block et al. (7) (outpatient versus inpatient) 
as follows: hematoma (12% versus 8%), numbness or weak- 
ness of limb (0.5% versus 1.60/o), cold or blue limb (1.6% 
versus 1.1%) and acute myocardial infarction (1.6% versus 
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of this study had arterial c 
decompression, repair or 
early ambulation portion 
ions req~~~ng surgery for 
reported (12,19) low vascular com~:icat~o~ rates of ~0.5% 
reflects improved equipment, use of heparin and extensive 
operator experience. 
Late (~3 weeks) sequelae sue doaneu r- 
mation or arteriovenous ftstula 1 artery r- 
ization have been rarely reported (22) and would not be 
identified in the current study with a follow-up period of only 
24 to 48 h. The incidence of this late complication is <O.Oi% 
(13-l&21). 
ILi This study was a clinical pilot safety trial of 
early n with large lumen 5F catheters. For direct 
comparison to larger catheters, two approaches could have 
been attempted: a 7F or 8F catheter placed in the contralat- 
era1 artery in the same patient or a randomized design of 
early ambulation with 5F or 8F catheters. The first approach 
would be generally unacceptable (and potentially unethical) 
to most patients. We were concerned with safety problems 
with <3 h ambulation with 8F catheter (g-13). Because of 
these methodologic limitations, only direct comparisons of 
angiography but not early ambulation with 8F catheters were 
performed. Therefore, comparative rates of hematoma and 
vascular complications from previous studies in >2 
cases (10,12,17,19) using standard 7F or 8F catheters were 
utilized. The published complication rates and incidence of 
hematoma formation are currently very low and achieved 
with bedrest under standard protocols of approximately 8 h. 
s. A~t~o~~h small in number, irn 
catheters were used successfully without requiring cat 
system was low. The angiographic data quality was uncom- 
promised, a feature that otfsets disadvantages currently 
limiting the widespread clinical use of small dia 
eters. Although we did not compute the direct cost savings 
of increasing patient turnover projected for an outpatient 
facility, it is apyu. _. -“rent that the fixed costs will be reduced by 
higher patient volume. Eariy discharge after early ambula- 
tion has the potential to improve outpatient catheterization 
cost factors by increasing facility utilization. 
We thank the J. C. Mudd Cardiac Catheterization Laboratory team. Mary 
Glosemeyer, RN and Neal G. Keller of Sherwood Medical Company. We also 
thank Donna Sander for manuscript preparation. 
Code definitions 
I, Emergency catheterization performed for critical illness that 
could not be deferred because of shock, refractory pain or hemo- 
dynamic compromise 
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2. Urgent catheterization performed in a timely fashion, usually 
the same day, for unstable conditions potentially necessitating 
intervention 
3. Elective catheterizations performed at prearranged time -Jr 
patients with stable clinical conditions including angina f.*‘: jris, 
congestive heart failure, atypical angina pectoris or valvular heart 
disease 
4. Other/miscellaneous (for example, preoperative evaluation, 
stable but needing urgent study) 
Codes for Conditions* 
I. 
2. 
3. 
4. 
5. 
6. 
I. 
8. 
9. 
IO. 
Unstable angina 
Cardiogenic shock 
Stable angina 
Atypical angina1 chest pain 
Acute or recent myocardial infarction 
Myocardial disease 
Follow-up percutaneous transluminal coronary angiography 
Follow-up coronary artery bypass graft surgery 
Congestive heart failure 
Other/miscellaneous (for example, postinfarction angina/ 
hypotension) 
Early Ambulation Follow-Up Euestionnaire 
1. Did you experience any discomfort around the catheterization 
site last night? 
2. Did you notice any bleeding from the site? 
3. Did you experience any numbness, tingling or weakness in any 
arm, leg or part of the face? 
4. Did you have any chest discomfort or chest pain throughout the 
night? 
4a. How long did your chest pain last? Did you take any medications 
to relieve the pain? 
5. Were you able to walk without pain or discomfort in the leg of 
the procedure? 
6. Have you noticed any swelling or an iucrease in swelling around 
the catheterization site? 
7. Have you noticed a change in color or increased discoloration 
around the catheterization site? 
*Definitions from reference 24. 14. 
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